Mechanisms of enveloped RNA virus budding

Trends in Cell Biology

Volumn 12, Issue 12, 2002, Pages 569-579

  Pornillos, Owen ^a   Garrus, Jennifer E ^a   Sundquist, Wesley I ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE; CYTOPLASM VESICLE; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR MIMICRY; PROTEIN TRANSPORT; REVIEW; RNA VIRUS; VIROLOGY; VIRUS ASSEMBLY; BIOGENESIS; BUD; BUDDING; COMPARTMENT MODEL; CYTOLOGY; ENDOSOME; HOST CELL; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; VIRUS ENVELOPE;

CELL MEMBRANE; CYTOPLASMIC VESICLES; HIV; HUMANS; MOLECULAR MIMICRY; PROTEIN TRANSPORT; RNA VIRUSES; VIRUS ASSEMBLY;

UBIQUITIN; VIRUS RNA;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0036900880     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)02402-9     Document Type: Review

References (112)

1. Marais, H. and Wilson, A. (2002) The report on the global HIV/AIDS epidemic. The Barcelona report. XIV International Conference on AIDS.
2. Ghendon Y. Influenza-its impact and control. World Health Stat. Q. 45:1992;306-311.
3. Eckert D.M., Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:2001;777-810.
4. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:2000;531-569.
5. Brunger A.T. Structural insights into the molecular mechanism of calcium-dependent vesicle-membrane fusion. Curr. Opin. Struct. Biol. 11:2001;163-173.
6. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat. Med. 8:2002;673-680.
7. Gottlinger H.G. The HIV-1 assembly machine. AIDS. 15:(Suppl. 5):2001;S13-S20.
8. Gottlinger H.G., et al. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U. S. A. 88:1991;3195-3199.
9. Huang M., et al. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:1995;6810-6818.
10. Wills J.W., Craven R.C. Form, function, and use of retroviral gag proteins. AIDS. 5:1991;639-654.
11. VerPlank L., et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7724-7729.
12. Garrus J.E., et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 107:2001;55-65.
13. Martin-Serrano J., et al. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7:2001;1313-1319.
14. Demirov D.G., et al. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U. S. A. 99:2002;955-960.
15. Katzmann D.J., et al. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell. 106:2001;145-155.
16. Patnaik A., et al. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13069-13074.
17. Piper R.C., Luzio J.P. Late endosomes: sorting and partitioning in multivesicular bodies. Traffic. 2:2001;612-621.
18. Raymond C.K., et al. Morphological classification of the yeast vacuolar protein sorting mutants: evidence for a prevacuolar compartment in class E vps mutants. Mol. Biol. Cell. 3:1992;1389-1402.
19. Rieder S.E., et al. Multilamellar endosome-like compartment accumulates in the yeast vps28 vacuolar protein sorting mutant. Mol. Biol. Cell. 7:1996;985-999.
20. Odorizzi G., et al. Fab1p PtdIns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell. 95:1998;847-858.
21. Asao H., et al. Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J. Biol. Chem. 272:1997;32785-32791.
22. Bean A.J., et al. Hrs-2 regulates receptor-mediated endocytosis via interactions with Eps15. J. Biol. Chem. 275:2000;15271-15278.
23. Shih S.C., et al. Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in receptor endocytosis. Nat. Cell Biol. 4:2002;389-393.
24. Raiborg C., et al. FYVE and coiled-coil domains determine the specific localisation of Hrs to early endosomes. J. Cell Sci. 114:2001;2255-2263.
25. Raiborg C., et al. Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Nat. Cell Biol. 4:2002;394-398.
26. Babst M., et al. Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev. Cell. 3:2002;283.
27. Babst M., et al. Escrt-III. An endosome-associated heterooligomeric protein complex required for mvb sorting. Dev. Cell. 3:2002;271.
28. Babst M., et al. The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. EMBO J. 17:1998;2982-2993.
29. Howard T.L., et al. CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins. J. Cell Sci. 114:2001;2395-2404.
30. Bishop N., Woodman P. TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes. J. Biol. Chem. 276:2001;11735-11742.
31. Wurmser A.E., Emr S.D. Phosphoinositide signaling and turnover: PtdIns(3)P, a regulator of membrane traffic, is transported to the vacuole and degraded by a process that requires lumenal vacuolar hydrolase activities. EMBO J. 17:1998;4930-4942.
32. Gillooly D.J., et al. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 19:2000;4577-4588.
33. Kobayashi T., et al. Localization of lysobisphosphatidic acid-rich membrane domains in late endosomes. Biol. Chem. 382:2001;483-485.
34. Schmid S.L., et al. Dynamin and its partners: a progress report. Curr. Opin. Cell Biol. 10:1998;504-512.
35. Wills J.W., et al. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 68:1994;6605-6618.
36. Xiang Y., et al. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J. Virol. 70:1996;5695-5700.
37. Yuan B., et al. Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:1999;4700-4710.
38. Yasuda J., Hunter E. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J. Virol. 72:1998;4095-4103.
39. Harty R.N., et al. A PPxY motif within the VP40 protein of ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13871-13876.
40. Craven R.C., et al. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J. Virol. 73:1999;3359-3365.
41. Jayakar H.R., et al. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J. Virol. 74:2000;9818-9827.
42. Strack B., et al. Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. J. Virol. 76:2002;5472-5479.
43. Wang H., et al. Analysis of bovine leukemia virus gag membrane targeting and late domain function. J. Virol. 76:2002;8485-8493.
44. Le Blanc I., et al. The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process. J. Virol. 76:2002;10024-10029.
45. Puffer B.A., et al. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71:1997;6541-6546.
46. Parent L.J., et al. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 69:1995;5455-5460.
47. Strack B., et al. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13063-13068.
48. Yuan B., et al. Infectivity of moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J. Virol. 74:2000;7250-7260.
49. Li F., et al. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. J. Virol. 76:2002;1569-1577.
50. Harty R.N., et al. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J. Virol. 73:1999;2921-2929.
51. Kikonyogo A., et al. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;11199-11204.
52. Harty R.N., et al. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J. Virol. 75:2001;10623-10629.
53. Yasuda J., et al. Functional involvement of a novel Nedd4-like ubiquitin ligase on retrovirus budding. EMBO Rep. 3:2002;636-640.
54. Rotin D., et al. Ubiquitination and endocytosis of plasma membrane proteins: role of Nedd4/Rsp5p family of ubiquitin-protein ligases. J. Membr. Biol. 176:2000;1-17.
55. Collins B.M., et al. Molecular architecture and functional model of the endocytic AP2 complex. Cell. 109:2002;523-535.
56. Puffer B.A., et al. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly. J. Virol. 72:1998;10218-10221.
57. Demirov D.G., et al. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J. Virol. 76:2002;105-117.
58. Dunn R., Hicke L. Domains of the rsp5 ubiquitin-protein ligase required for receptor- mediated and fluid-phase endocytosis. Mol. Biol. Cell. 12:2001;421-435.
59. Wang G., et al. Localization of the Rsp5p ubiquitin-protein ligase at multiple sites within the endocytic pathway. Mol. Cell. Biol. 21:2001;3564-3575.
60. Hirst J., Robinson M.S. Clathrin and adaptors. Biochim. Biophys. Acta. 1404:1998;173-193.
61. Traub L.M., et al. AP-2-containing clathrin coats assemble on mature lysosomes. J. Cell Biol. 135:1996;1801-1814.
62. Schubert U., et al. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13057-13062.
63. Reggiori F., Pelham H.R. Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting. EMBO J. 20:2001;5176-5186.
64. Longva K.E., et al. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156:2002;843-854.
65. Urbanowski J.L., Piper R.C. Ubiquitin sorts proteins into the intralumenal degradative compartment of the late-endosome/vacuole. Traffic. 2:2001;622-630.
66. Polo S., et al. A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins. Nature. 416:2002;451-455.
67. Bishop N., et al. Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates. J. Cell Biol. 157:2002;91-101.
68. Amerik A.Y., et al. The Doa4 deubiquitinating enzyme is functionally linked to the vacuolar protein-sorting and endocytic pathways. Mol. Biol. Cell. 11:2000;3365-3380.
69. Ott D.E., et al. Equine infectious anemia virus and the ubiquitin-proteasome system. J. Virol. 76:2002;3038-3044.
70. Patnaik A., et al. Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J. Virol. 76:2002;2641-2647.
71. Ott D.E., et al. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. J. Virol. 72:1998;2962-2968.
72. Ott D.E., et al. Ubiquitination of HIV-1 and MuLV Gag. Virology. 278:2000;111-121.
73. Koonin E.V., Abagyan R.A. TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat. Genet. 16:1997;330-331.
74. Ponting C.P., et al. The breast cancer gene product TSG101: a regulator of ubiquitination? J. Mol. Med. 75:1997;467-469.
75. Pornillos O., et al. Structure and functional interactions of the Tsg101 UEV domain. EMBO J. 21:2002;2397-2406.
76. Pornillos, O.P. et al. Structure of the Tsg101 UEV domain in complex with a HIV-1 PTAP 'late domain' peptide, Nat. Struct. Biol. (in press).
77. Zarrinpar A., Lim W.A. Converging on proline: the mechanism of WW domain peptide recognition. Nat. Struct. Biol. 7:2000;611-613.
78. Owen D.J., Evans P.R. A structural explanation for the recognition of tyrosine-based endocytotic signals. Science. 282:1998;1327-1332.
79. Komada M., et al. Hrs, a tyrosine kinase substrate with a conserved double zinc finger domain, is localized to the cytoplasmic surface of early endosomes. J. Biol. Chem. 272:1997;20538-20544.
80. Zimmerman C., et al. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature. 415:2002;88-92.
81. Campbell S., et al. Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10875-10879.
82. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74:2000;3264-3272.
83. Lindwasser O.W., Resh M.D. Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75:2001;7913-7924.
84. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U. S. A. 98:2001;13925-13930.
85. Bavari S., et al. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195:2002;593-602.
86. Scheiffele P., et al. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274:1999;2038-2044.
87. Muller B., et al. The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles. J. Virol. 76:2002;1015-1024.
88. Marsh M., Pelchen-Matthews A. Endocytosis in viral replication. Traffic. 1:2000;525-532.
89. Geyer M., et al. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2:2001;580-585.
90. Bour S., Strebel K. HIV accessory proteins: multifunctional components of a complex system. Adv. Pharmacol. 48:2000;75-120.
91. Raposo G., et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic. 3:2002;718-729.
92. Denzer K., et al. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113:2000;3365-3374.
93. Blom J., et al. An ultrastructural study of HIV-infected human dendritic cells and monocytes/macrophages. APMIS. 101:1993;672-680.
94. Pautrat G., et al. Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. Virology. 179:1990;749-758.
95. Meltzer M.S., et al. Macrophages and the human immunodeficiency virus. Immunol. Today. 11:1990;217-223.
96. Kolesnikova L., et al. VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J. Virol. 76:2002;1825-1838.
97. Rossio J.L., et al. HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis. AIDS Res. Hum. Retroviruses. 11:1995;1433-1439.
98. Geijtenbeek T.B., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 100:2000;587-597.
99. Kwon D.S., et al. DC-SIGN-mediated internalization of HIV is required for trans- enhancement of T cell infection. Immunity. 16:2002;135-144.
100. Engering A., et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2002;2118-2126.
101. Hicke L. Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol. 9:1999;107-112.
102. Kramer H. Sorting out signals in fly endosomes. Traffic. 3:2002;87-91.
103. Turley S.J., et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288:2000;522-527.
104. Kleijmeer M.J., et al. Antigen loading of MHC class I molecules in the endocytic tract. Traffic. 2:2001;124-137.
105. Li L., et al. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1619-1624.
106. Oh H., et al. Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5430-5435.
107. Krempler A., et al. Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53 independent cell death. J. Biol. Chem. 29:2002;29.
108. Hyatt A.D., et al. Localization of the non-structural protein NS3 in bluetongue virus- infected cells. J. Gen. Virol. 72:1991;2263-2267.
109. Fraile-Ramos A., et al. Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes. Traffic. 3:2002;218-232.
110. Ruland J., et al. p53 Accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1859-1864.
111. Miura S., et al. Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol. Cell. Biol. 20:2000;9346-9355.
112. Huang X., et al. Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat. Struct. Biol. 7:2000;634-638.